Loading...
Turning enemies into allies—reprogramming tumor-associated macrophages for cancer therapy
Checkpoint blockade therapies that target inhibitory receptors on T cells have revolutionized clinical oncology. Antibodies targeting CTLA-4 or the PD-1/PD-L1 axis are now successfully used alone or in combination with chemotherapy for numerous tumor types. Despite the clinical success of checkpoint...
Na minha lista:
| Udgivet i: | Med (N Y) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8238417/ https://ncbi.nlm.nih.gov/pubmed/34189494 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.medj.2021.05.001 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|